Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2013, Vol. 33 Issue (12): 127-132    DOI:
    
Problems and Solutions in the Drafting of Biotechnological Patents
WU Xue-mei, QU Kai
Patent Examination Cooperation Center of the Patent Office, SIPO, Beijing 100190, China
Download: HTML   PDF(439KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  The Biotechnological patent application is somewhat special in technology exertion, law and regulations and social ethics. The common problems and solutions in this field were analyzed, including subject matters for which no patent right shall be granted, insufficient disclosure of the invention, unsuitably generalization of claims and so on. It will provide enough help for patent drafting in this field.

Key wordsExamination      Biotechnology      Patent      Draft      Strategy     
Received: 09 October 2013      Published: 25 December 2013
ZTFLH:  D923  
Cite this article:

WU Xue-mei, QU Kai. Problems and Solutions in the Drafting of Biotechnological Patents. China Biotechnology, 2013, 33(12): 127-132.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2013/V33/I12/127

[1] 张清奎.医药及生物领域发明专利申请文件的撰写与审查.北京:知识产权出版社, 2002.35-37. Zhang Q K. Patent Drafting and Examination in Medical and Biological Fields. BeiJing: Intellectual Property Publishing House, 2002. 35-37.
[2] 中华人民共和国知识产权局.审查指南. 北京:知识产权出版社, 2010.130-277. State Intellectual Property Office of The People's Republic of China. Guidelines For Patent Examination. BeiJing: Intellectual Property Publishing House, 2010. 130-277.
[1] LIU Xu-xia,YANG An-ke. An Analysis of the U.S. SECURE Rule and Its Enlightenment to China[J]. China Biotechnology, 2021, 41(9): 126-135.
[2] HU Yuan-lei,CHEN Yan-cheng,PU Run,YAO Wei-hao,ZHANG Hong-xiang. Bio-tech Startup Incubation Best Practice in the United Kingdom and Suggestion[J]. China Biotechnology, 2021, 41(4): 100-105.
[3] CHEN Ying,LI Qian. Patent Analysis on the Development Trend of Industrial Application of Special Yeast[J]. China Biotechnology, 2021, 41(4): 91-99.
[4] WU Han-rong,WANG Ying,HUANG Ying-ming,LI Dong-xue,LI Zhi-fei,FANG Zi-han,FAN Lin. Promote the Innovation and Transformation of Biotechnology by Base Platform[J]. China Biotechnology, 2021, 41(12): 141-147.
[5] WU Han-rong,WANG Ying,YANG Li,GE Yao,FAN Ling. Current Situation and Development Suggestions of China’s Biotechnology Base Platform[J]. China Biotechnology, 2021, 41(11): 119-123.
[6] WU Han-rong,WANG Ying,LI Su-ning,SANG Xiao-dong,FAN Ling. Policy Research on the Construction of Biotechnology Base Platforms in China[J]. China Biotechnology, 2021, 41(10): 127-131.
[7] SHI Peng-cheng, JI Xiao-jun. Advances in Expression of Human Epidermal Growth Factor in Yeast[J]. China Biotechnology, 2021, 41(1): 72-79.
[8] WANG Xiao-li. The Age of Biosecurity: New Biotechnology Revolution and National Biosecurity Governance[J]. China Biotechnology, 2020, 40(9): 95-109.
[9] SONG Yi-mei,JIA Xiu-wei,LI Shu-biao,GAO Cui-juan. Industrial Microorganism of Yarrowia lipolytica and Its Industrial Amplicaiton[J]. China Biotechnology, 2020, 40(9): 77-86.
[10] YANG Na,WU Qun,XU Yan. Fermentation Optimization for the Production of Surfactin by Bacillus amyloliquefaciens[J]. China Biotechnology, 2020, 40(7): 51-58.
[11] JIANG Tian,ZHANG Chao,LIU Hui-zhou. Development Trends Analysis of Microbial Fuel Cell[J]. China Biotechnology, 2020, 40(1-2): 189-197.
[12] XIE Hua-ling,LV Lu-cheng,YANG Yan-ping. Patent Analysis of Global Coronavirus Vaccine[J]. China Biotechnology, 2020, 40(1-2): 57-64.
[13] ZHAO Ping,YANG Yan-ping. Patent Situation Analysis of Diagnosis Technology for Coronavirus Infection in Human[J]. China Biotechnology, 2020, 40(1-2): 51-56.
[14] LI Dong-qiao,LV Lu-cheng,YANG Yan-ping. The Research Status and Development Trend of Global Human Coronavirus Antibody Field[J]. China Biotechnology, 2020, 40(1-2): 65-70.
[15] HUANG Peng-fei,CHEN Yun,LU Jiao,MAO Kai-yun,YUAN Yin-chi. Development Situation and Suggestions of Biomedicine Patent-intensive Industry, Based on the Case Study of Shanghai[J]. China Biotechnology, 2020, 40(12): 108-116.